{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:19:21Z","timestamp":1707524361095},"reference-count":5,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,5]]},"DOI":"10.7759\/cureus.16921","type":"journal-article","created":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:53:58Z","timestamp":1628211238000},"source":"Crossref","is-referenced-by-count":1,"title":["Rituxan-Induced Tumor Lysis Syndrome in a Patient With Diffuse Large B-Cell Lymphoma"],"prefix":"10.7759","author":[{"given":"Saffa","family":"Iftikhar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waleed","family":"Khokher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Gekonde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nithin","family":"Kesireddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabath","family":"Mudiyanselage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-200211002-00002","article-title":"Mechanism of action of rituximab","volume":"13","author":"Cerny T","year":"2002","unstructured":"Cerny T, Borisch B, Introna M, Johnson P, Rose AL. Mechanism of action of rituximab. Anticancer Drugs. 2002, 13:3-10. 10.1097\/00001813-200211002-00002","journal-title":"Anticancer Drugs"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0904569","article-title":"The tumor lysis syndrome","volume":"364","author":"Howard SC","year":"2011","unstructured":"Howard SC, Jones DP, Pui CH. The tumor lysis syndrome. N Engl J Med. 2011, 364:1844-54. 10.1056\/NEJMra0904569","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2668","article-title":"Current understanding of tumor lysis syndrome","volume":"37","author":"Rahmani B","year":"2019","unstructured":"Rahmani B, Patel S, Seyam O, Gandhi J, Reid I, Smith N, Khan SA. Current understanding of tumor lysis syndrome. Hematol Oncol. 2019, 37:537-47. 10.1002\/hon.2668","journal-title":"Hematol Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e318244db6f","article-title":"Diagnosis and treatment of rituximab-induced acute tumor lysis syndrome in patients with diffuse large B-cell lymphoma","volume":"343","author":"Yang B","year":"2012","unstructured":"Yang B, Lu XC, Yu RL&lt; et al.. Diagnosis and treatment of rituximab-induced acute tumor lysis syndrome in patients with diffuse large B-cell lymphoma. Am J Med Sci. 2012, 343:337-41. 10.1097\/MAJ.0b013e318244db6f","journal-title":"Am J Med Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.0177","article-title":"Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review","volume":"26","author":"Coiffier B","year":"2008","unstructured":"Coiffier B, Altman A, Pui CH, Younes A, Cairo MS. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol. 2008, 26:2767-78. 10.1200\/JCO.2007.15.0177","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/61778-rituxan-induced-tumor-lysis-syndrome-in-a-patient-with-diffuse-large-b-cell-lymphoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:46Z","timestamp":1707507226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/61778-rituxan-induced-tumor-lysis-syndrome-in-a-patient-with-diffuse-large-b-cell-lymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,5]]},"references-count":5,"URL":"https:\/\/doi.org\/10.7759\/cureus.16921","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,5]]}}}